EXTRACTION AND ISOLATION OF ALKALOIDS OF SOPHORA ALOPECUROIDES AND THEIR ANTI-TUMOR EFFECTS IN H22 TUMOR-BEARING MICE
Background: Alkaloids of Sophora alopecuroides have good biological activity, and are widely used in clinical settings, which not only have pharmacological activities of anti-cancer, cancer suppression, as well as the inhibition, and killing of various microorganisms; but also possess extensive phar...
Gespeichert in:
Veröffentlicht in: | African journal of traditional, complementary, and alternative medicines complementary, and alternative medicines, 2014-01, Vol.11 (2), p.245-248 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Alkaloids of Sophora alopecuroides have good biological
activity, and are widely used in clinical settings, which not only have
pharmacological activities of anti-cancer, cancer suppression, as well
as the inhibition, and killing of various microorganisms; but also
possess extensive pharmacological effects on immune system, nervous
system and cardiovascular system. The objective of this paper was to
extract and isolate total alkaloids of Sophora alopecuroides (TASA),
and to study their anti-tumor effects in H22 tumor-bearing mice.
Materials and Methods: TASA were extracted and isolated using
thin-layer chromatography, and column chromatography; and the isolated
compounds were analyzed using nuclear magnetic resonance. The
inhibitory effects of TASA on tumor in H22-bearing mice were determined
by MTT assay. Results: Three compounds were isolated from Sophora
alopecuroides L., which were matrine, oxymatrine and sophoridine,
respectively. Meanwhile, mouse H22 sarcoma model was established and
different doses of TASA apparently inhibited solid H22-tumor in mice;
it inhibited the thymus, and spleen to some extent; the degree of
inhibition was more obvious for the spleen. Conclusion: TASA has an
anti-tumor effect in H22 tumor-bearing mice. |
---|---|
ISSN: | 0189-6016 2505-0044 0189-6016 |
DOI: | 10.4314/ajtcam.v11i2.3 |